Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients

NCT01579812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Interventions

DRUG: Metformin

Sponsor

University of Michigan Rogel Cancer Center